Efficacy, Safety, and Tolerability Topical Nasal Spray in the Prevention of SARS-CoV-2 Infection in Healthcare Personnel

Efficacy, Safety, and Tolerability Topical Nasal Spray in the Prevention of SARS-CoV-2 Infection in Healthcare Personnel

Brief description of study

The purpose of this study is to assess the effectiveness, safety, and tolerability of GLS-1200 to prevent SARS-CoV-2 infection in healthcare personnel. GLS-1200 contains quinine diluted in saline (salt water). Pre-clinical studies have shown that quinine stimulates nasal cells to secrete compounds that may prevent growth of bacteria and reduce viruses from reproducing. 

Detailed description of study

Treatment: Participants will be randomized to either quinine or placebo group (saline or salt water) at a 2:1 ratio. 
 Duration of the Study: Participants will self-administer study drug three times daily (TID) for 4 weeks. A follow-up visit will be made at 6 weeks to assess participant health since some cases of SARS-CoV-2 infection may not be apparent until after the treatment period has ended.

Click below to see if you may be eligible:
 

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    covid-19,healthcare workers
  • Age: Between 18 Years - 90 Years
  • Gender: All

Requirements to Enter the Study: 

  • Participants must be ≥ 18 years of age and a healthcare professional. 
  • Participants must not have had a confirmed prior positive test for SARS-CoV-2, or treatment within the past 2 weeks with chloroquine, hydroxychloroquine, or remdesivir.
  • No known allergy to quinine, quinidine or mefloquine. 
  • Able and willing to utilize an approved form of pregnancy prevention for women of child-bearing potential through to the end of treatment. 
Interested participants please fill out the survey below:

https://redcap.med.upenn.edu/surveys/?s=JHNY9RPHDK

Updated on 05 Nov 2020. Study ID: 843133

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center